Literature DB >> 21503710

The relationship between cognitive impairment and diabetes self-management in a population-based community sample of older adults with Type 2 diabetes.

Denise G Feil1, Carolyn W Zhu, David L Sultzer.   

Abstract

Although nearly one-third of older diabetics are cognitively impaired, their diabetes management remains poorly understood. To examine the relationship between cognitive impairment and diabetes self-management in a population-based community sample of older adults with Type 2 diabetes. Cross-sectional observational analysis. 1,398 persons with diabetes, aged 60 years or older, who responded to the 2003 Health and Retirement Study Diabetes Survey. We conducted logistic regressions on the effects of cognitive impairment on respondents' self-management ability after controlling for diabetes comorbidities, demographics, and clinical characteristics. Participants with greater cognitive impairment were less likely to adhere to exercise (Adjusted Odds ratio [AOR] = 0.725 and 0.712 for moderate and severe cognitive impairment, both P < 0.05), and to diet (AOR = 0.906 and 0.618 for moderate and severe cognitive impairment, both P < 0.01). Cognitive impairment is associated with worse self-care and may pose challenges to diabetic older persons, notably in diet and exercise. Cognitive screening may be indicated in this high risk group.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21503710     DOI: 10.1007/s10865-011-9344-6

Source DB:  PubMed          Journal:  J Behav Med        ISSN: 0160-7715


  54 in total

1.  Clinical outcomes and adherence to medications measured by claims data in patients with diabetes.

Authors:  Manel Pladevall; L Keoki Williams; Lisa Ann Potts; George Divine; Hugo Xi; Jennifer Elston Lafata
Journal:  Diabetes Care       Date:  2004-12       Impact factor: 19.112

2.  Adherence to antiretroviral medications in HIV: differences in data collected via self-report and electronic monitoring.

Authors:  Andrew J Levine; Charles H Hinkin; Sarah Marion; Allison Keuning; Steven A Castellon; Mona M Lam; Marta Robinet; Douglas Longshore; Thomas Newton; Hector Myers; Ramani S Durvasula
Journal:  Health Psychol       Date:  2006-05       Impact factor: 4.267

3.  Executive function, working memory, and medication adherence among older adults.

Authors:  Kathleen Insel; Daniel Morrow; Barbara Brewer; Aurelio Figueredo
Journal:  J Gerontol B Psychol Sci Soc Sci       Date:  2006-03       Impact factor: 4.077

4.  Development and validation of the Diabetes Care Profile.

Authors:  J T Fitzgerald; W K Davis; C M Connell; G E Hess; M M Funnell; R G Hiss
Journal:  Eval Health Prof       Date:  1996-06       Impact factor: 2.651

5.  Starting insulin therapy in patients with type 2 diabetes: effectiveness, complications, and resource utilization.

Authors:  R A Hayward; W G Manning; S H Kaplan; E H Wagner; S Greenfield
Journal:  JAMA       Date:  1997-11-26       Impact factor: 56.272

6.  Medication adherence in HIV-infected adults: effect of patient age, cognitive status, and substance abuse.

Authors:  Charles H Hinkin; David J Hardy; Karen I Mason; Steven A Castellon; Ramani S Durvasula; Mona N Lam; Marta Stefaniak
Journal:  AIDS       Date:  2004-01-01       Impact factor: 4.177

7.  Diabetes mellitus and the risk of dementia, Alzheimer's disease and vascular cognitive impairment in the Canadian Study of Health and Aging.

Authors:  Chris MacKnight; Kenneth Rockwood; Erin Awalt; Ian McDowell
Journal:  Dement Geriatr Cogn Disord       Date:  2002       Impact factor: 2.959

8.  Patient empowerment. Results of a randomized controlled trial.

Authors:  R M Anderson; M M Funnell; P M Butler; M S Arnold; J T Fitzgerald; C C Feste
Journal:  Diabetes Care       Date:  1995-07       Impact factor: 19.112

9.  Medication adherence and associated hemoglobin A1c in type 2 diabetes.

Authors:  Kimberley Krapek; Kathleen King; Susan S Warren; Karen G George; Dorothy A Caputo; Karen Mihelich; Elizabeth M Holst; Michael B Nichol; Sheng G Shi; Kevin B Livengood; Steve Walden; Teresa J Lubowski
Journal:  Ann Pharmacother       Date:  2004-07-06       Impact factor: 3.154

10.  Alzheimer disease in the US population: prevalence estimates using the 2000 census.

Authors:  Liesi E Hebert; Paul A Scherr; Julia L Bienias; David A Bennett; Denis A Evans
Journal:  Arch Neurol       Date:  2003-08
View more
  46 in total

1.  Adherence to diabetes guidelines for screening, physical activity and medication and onset of complications and death.

Authors:  Yiqun Chen; Frank A Sloan; Arseniy P Yashkin
Journal:  J Diabetes Complications       Date:  2015-07-09       Impact factor: 2.852

2.  Independent and interactive impacts of hypertension and diabetes mellitus on verbal memory: A coordinated analysis of longitudinal data from England, Sweden, and the United States.

Authors:  Amanda Kelly; Matthew Calamia; Andrey Koval; Graciela Muniz Terrera; Andrea M Piccinin; Sean Clouston; Linda B Hassing; David A Bennett; Boo Johansson; Scott M Hofer
Journal:  Psychol Aging       Date:  2016-02-25

3.  Patient Engagement With an Automated Telephone Symptom Management Intervention: Predictors and Outcomes.

Authors:  Alla Sikorskii; Charles W Given; Barbara A Given; Asish Banik; John C Krauss
Journal:  Ann Behav Med       Date:  2020-06-12

Review 4.  Diabetes, Depression, and Cognition: a Recursive Cycle of Cognitive Dysfunction and Glycemic Dysregulation.

Authors:  Sheila Black; Kyle Kraemer; Avani Shah; Gaynell Simpson; Forrest Scogin; Annie Smith
Journal:  Curr Diab Rep       Date:  2018-09-28       Impact factor: 4.810

5.  Impairment of cognitive flexibility in type 2 diabetic db/db mice.

Authors:  Leonid M Yermakov; Ryan B Griggs; Domenica E Drouet; Chiho Sugimoto; Michael T Williams; Charles V Vorhees; Keiichiro Susuki
Journal:  Behav Brain Res       Date:  2019-05-26       Impact factor: 3.332

Review 6.  Assessing premorbid cognitive ability in adults with type 2 diabetes mellitus--a review with implications for future intervention studies.

Authors:  Rachel Heloise Xiwen Wong; Andrew Scholey; Peter Ranald Charles Howe
Journal:  Curr Diab Rep       Date:  2014       Impact factor: 4.810

7.  Type 2 Diabetes Interacts With Alzheimer Disease Risk Factors to Predict Functional Decline.

Authors:  Kelsey R Thomas; Katherine J Bangen; Alexandra J Weigand; Emily C Edmonds; Erin Sundermann; Christina G Wong; Joel Eppig; Madeleine L Werhane; Lisa Delano-Wood; Mark W Bondi
Journal:  Alzheimer Dis Assoc Disord       Date:  2020 Jan-Mar       Impact factor: 2.703

8.  Hyponatremia and Cognitive Impairment in Patients Treated with Peritoneal Dialysis.

Authors:  Rong Xu; Hai-chen Pi; Zu-ying Xiong; Jin-lan Liao; Li Hao; Gui-ling Liu; Ye-Ping Ren; Qin Wang; Zhao-xia Zheng; Li-ping Duan; Jie Dong
Journal:  Clin J Am Soc Nephrol       Date:  2015-07-31       Impact factor: 8.237

9.  Prefrontal cortex brain damage and glycemic control in patients with type 2 diabetes.

Authors:  Sarah E Choi; Bhaswati Roy; Matthew Freeby; Rashmi Mullur; Mary A Woo; Rajesh Kumar
Journal:  J Diabetes       Date:  2020-01-14       Impact factor: 4.006

10.  Self-care in People with Type 2 Diabetes Mellitus Research Protocol of a Multicenter Mixed Methods Study (SCUDO)

Authors:  Michela Luciani; Diletta Fabrizi; Paola Rebora; Emanuela Rossi; Stefania Di Mauro; Susan Kohl Malone; Davide Ausili
Journal:  Prof Inferm       Date:  2019 Jul - Sep
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.